Skip to main content
Clinical Trials/CTRI/2022/06/043141
CTRI/2022/06/043141Completed未知

Efficacy Of Vallipanchamula Churna In The Management Of Madhumeha w.s.r To Type 2 Diabetes Mellitus - An Open Labeled Randomized Controlled Clinical Trial

Government Akhandanand College And Hospital0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Classical signs and symptoms of Madhumeha-
  • PrabhutaavilaMutrata, pipasadhikya, kshudhadhikya, swedadhikya, Nidradhikya, karapadataladaha, karapadatalasuptata, angagandha, daurbalya, shrama, galatalushosha, tandra
  • 2)Fasting plasma glucose upto 200 mg/dl and post prandial glucose level upto 300mg/dl
  • 3)Both insulin dependent and non insulin dependent type 2 diabetes mellitus patients will be included
  • 4)Both newly diagnose and patients on allopathic treatment will be included in this study

Exclusion Criteria

  • 1)Patients with other metabolic and endocrinal disorders.
  • 2)Patients having uncontrolled blood sugar.
  • 3)Fasting plasma glucose level more than 200mg/dl & post prandial glucose level more than 300mg/dl will be excluded
  • 4)Patients having any other malignancies, any other systemic / serious illness.
  • 5)Patients with diabetic wound / ulcers.
  • 6)Patients of Diabetes mellitus Type 1 (Juvenile Diabetes).
  • 7)Patients having acute & serious complications of Type 2 Diabetes Mellitus.
  • 8)Patients with Coronary artery disease, Peripheral vascular disease & cerebrovascular disease &
  • 9)Other chronic debilitating disease like STD, Tuberculosis etc.
  • 10)Pregnant women

Investigators

Sponsor
Government Akhandanand College And Hospital

Similar Trials